{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:05:20Z","timestamp":1776276320244,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00198-014-2910-3","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T07:15:10Z","timestamp":1412061310000},"page":"601-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only"],"prefix":"10.1007","volume":"26","author":[{"given":"C.-C.","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.-M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-P.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.-H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-T.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-Y.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"2910_CR1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jbmr.5650040314","volume":"4","author":"C Movsowitz","year":"1989","unstructured":"Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S (1989) Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 4:393\u2013398","journal-title":"J Bone Miner Res"},{"key":"2910_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","volume":"27","author":"NE Lane","year":"1998","unstructured":"Lane NE, Lukert B (1998) The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 27:465\u2013483","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2910_CR3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","volume":"11","author":"T Koga","year":"2005","unstructured":"Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H (2005) NFAT and Osterix cooperatively regulate bone formation. Nat Med 11:880\u2013885","journal-title":"Nat Med"},{"key":"2910_CR4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP Staa van","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383\u20131389","journal-title":"Rheumatology (Oxford)"},{"key":"2910_CR5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00198-013-2587-z","volume":"25","author":"IE Bultink","year":"2014","unstructured":"Bultink IE, Harvey NC, Lalmohamed A, Cooper C, Lems WF, van Staa TP, de Vries F (2014) Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom. Osteoporos Int 25:1275\u20131283","journal-title":"Osteoporos Int"},{"key":"2910_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"2910_CR7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","volume":"68","author":"M Baum","year":"2005","unstructured":"Baum M, Schiavi S, Dwarakanath V, Quigley R (2005) Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int 68:1148\u20131153","journal-title":"Kidney Int"},{"key":"2910_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"2910_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik T, Bj\u00f6rklund P, Marsell R, Ljunggren O, Akerstr\u00f6m G, Jonsson KB, Westin G, Larsson TE (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125\u2013131","journal-title":"J Endocrinol"},{"key":"2910_CR10","first-page":"497","volume":"104","author":"E Celik","year":"2013","unstructured":"Celik E, Guzel S, Abali R, Guzelant AY, Celik Guzel E, Ku\u00e7ukyalcin V (2013) The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women. Minerva Med 104:497\u2013504","journal-title":"Minerva Med"},{"key":"2910_CR11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.263","volume":"26","author":"MA Mirza","year":"2011","unstructured":"Mirza MA, Karlsson MK, Mellstr\u00f6m D, Orwoll E, Ohlsson C, Ljunggren O, Larsson TE (2011) Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J Bone Miner Res 26:857\u2013864","journal-title":"J Bone Miner Res"},{"key":"2910_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0961203309345775","volume":"19","author":"SM Toloza","year":"2010","unstructured":"Toloza SM, Cole DE, Gladman DD, Iba\u00f1ez D, Urowitz MB (2010) Vitamin D insufficiency in a large female SLE cohort. Lupus 19:13\u201319","journal-title":"Lupus"},{"key":"2910_CR13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0961203311401457","volume":"20","author":"M Souto","year":"2011","unstructured":"Souto M, Coelho A, Guo C, Mendonca L, Argolo S, Papi J, Farias M (2011) Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 20:1019\u20131026","journal-title":"Lupus"},{"key":"2910_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/RHU.0b013e318289bd16","volume":"19","author":"S Chaiamnuay","year":"2013","unstructured":"Chaiamnuay S, Chailurkit LO, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P (2013) Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. J Clin Rheumatol 19:121\u2013125","journal-title":"J Clin Rheumatol"},{"key":"2910_CR15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00198-012-2157-9","volume":"24","author":"J Jacobs","year":"2013","unstructured":"Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BA, Lems WF, Voskuyl AE, Bultink IE (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827\u20131833","journal-title":"Osteoporos Int"},{"key":"2910_CR16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"2910_CR17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"2910_CR18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"2910_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","volume":"16","author":"JT Schousboe","year":"2013","unstructured":"Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom 16:455\u2013466","journal-title":"J Clin Densitom"},{"key":"2910_CR20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"2910_CR21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2011.09.019","volume":"59","author":"A Young","year":"2012","unstructured":"Young A, Hodsman AB, Boudville N, Geddes C, Gill J, Goltzman D, Jassal SV, Klarenbach S, Knoll G, Muirhead N et al (2012) Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation. Am J Kidney Dis 59:761\u2013769","journal-title":"Am J Kidney Dis"},{"key":"2910_CR22","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3899\/jrheum.111589","volume":"39","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Aghdassi E, Cheung AM, Morrison S, Cymet A, Peeva V, Neville C, Hewitt S, DaCosta D, Pineau C et al (2012) Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus. J Rheumatol 39:1378\u20131384","journal-title":"J Rheumatol"},{"key":"2910_CR23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu1036oa","volume":"13","author":"CA Pineau","year":"2004","unstructured":"Pineau CA, Urowitz MB, Fortin PJ, Ibanez D, Gladman DD (2004) Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 13:436\u2013441","journal-title":"Lupus"},{"key":"2910_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10067-008-0984-z","volume":"28","author":"C Mendoza-Pinto","year":"2009","unstructured":"Mendoza-Pinto C, Garc\u00eda-Carrasco M, Sandoval-Cruz H, Esc\u00e1rcega RO, Jim\u00e9nez-Hern\u00e1ndez M, Etchegaray-Morales I, Soto-Vega E, Mu\u00f1oz-Guarneros M, L\u00f3pez-Colombo A, Delez\u00e9-Hinojosa M et al (2009) Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol 28:65\u201370","journal-title":"Clin Rheumatol"},{"key":"2910_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0961203308094995","volume":"18","author":"SS Yeap","year":"2009","unstructured":"Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah S, Chow SK, Goh EM (2009) Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids. Lupus 18:178\u2013181","journal-title":"Lupus"},{"key":"2910_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00296-009-1244-5","volume":"31","author":"M Furukawa","year":"2011","unstructured":"Furukawa M, Kiyohara C, Tsukamoto H, Mitoma H, Kimoto Y, Uchino A, Nakagawa M, Oryoji K, Shimoda T, Akashi K et al (2011) Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. Rheumatol Int 31:365\u2013376","journal-title":"Rheumatol Int"},{"key":"2910_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jocd.2011.12.002","volume":"15","author":"MI Souto","year":"2012","unstructured":"Souto MI, Coelho A, Guo C, Mendonca LM, Pinheiro MF, Papi JA, Farias ML (2012) The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors. J Clin Densitom 15:320\u2013327","journal-title":"J Clin Densitom"},{"key":"2910_CR28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/37.4.405","volume":"37","author":"EK Li","year":"1998","unstructured":"Li EK, Tam LS, Young RP, Ko GT, Li M, Lau EM (1998) Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 37:405\u2013410","journal-title":"Br J Rheumatol"},{"key":"2910_CR29","first-page":"102","volume":"28","author":"S Lakshminarayanan","year":"2001","unstructured":"Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N (2001) Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 28:102\u2013108","journal-title":"J Rheumatol"},{"key":"2910_CR30","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/art.22691","volume":"56","author":"S Compeyrot-Lacassagne","year":"2007","unstructured":"Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED (2007) Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 56:1966\u20131973","journal-title":"Arthritis Rheum"},{"key":"2910_CR31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/jcp.2010.077842","volume":"64","author":"SK Sandhu","year":"2011","unstructured":"Sandhu SK, Hampson G (2011) The pathogenesis, diagnosis, investigation and management of osteoporosis. J Clin Pathol 64:1042\u20131050","journal-title":"J Clin Pathol"},{"key":"2910_CR32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/eci.13.19","volume":"9","author":"CC Mok","year":"2013","unstructured":"Mok CC (2013) Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol 9:453\u2013463","journal-title":"Expert Rev Clin Immunol"},{"key":"2910_CR33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/rheumatology\/keq307","volume":"50","author":"JC Baker-LePain","year":"2011","unstructured":"Baker-LePain JC, Nakamura MC, Shepherd J, von Scheven E (2011) Assessment of bone remodelling in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford) 50:611\u2013619","journal-title":"Rheumatology (Oxford)"},{"key":"2910_CR34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/s101650200057","volume":"12","author":"S Banno","year":"2002","unstructured":"Banno S, Matsumoto Y, Naniwa T, Hayami Y, Sugiura Y, Yoshinouchi T, Ueda R (2002) Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with glucocorticoids. Mod Rheumatol 12:323\u2013328","journal-title":"Mod Rheumatol"},{"key":"2910_CR35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1196\/annals.1346.053","volume":"1068","author":"H Yeo","year":"2006","unstructured":"Yeo H, McDonald JM, Zayzafoon M (2006) NFATc1: a novel anabolic therapeutic target for osteoporosis. Ann N Y Acad Sci 1068:564\u2013567","journal-title":"Ann N Y Acad Sci"},{"key":"2910_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1651-2227.1979.tb04969.x","volume":"68","author":"S O\u2019Regan","year":"1979","unstructured":"O\u2019Regan S, Chesney RW, Hamstra A, Eisman JA, O\u2019Gorman AM, Deluca HF (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68:109\u2013111","journal-title":"Acta Paediatr Scand"},{"key":"2910_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000328874","volume":"34","author":"CT Lee","year":"2011","unstructured":"Lee CT, Ng HY, Lien YH, Lai LW, Wu MS, Lin CR, Chen HC (2011) Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. Am J Nephrol 34:87\u201394","journal-title":"Am J Nephrol"},{"key":"2910_CR38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3164.2012.01119.x","volume":"23","author":"M Kovalik","year":"2012","unstructured":"Kovalik M, Mellanby RJ, Evans H, Berry J, van den Broek AH, Thoday KL (2012) Ciclosporin therapy is associated with minimal changes in calcium metabolism in dogs with atopic dermatitis. Vet Dermatol 23:481\u2013e491","journal-title":"Vet Dermatol"},{"key":"2910_CR39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI115947","volume":"90","author":"FA Gesek","year":"1992","unstructured":"Gesek FA, Friedman PA (1992) On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 90:749\u2013758","journal-title":"J Clin Invest"},{"key":"2910_CR40","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","volume":"28","author":"M Wolf","year":"2013","unstructured":"Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28:1793\u20131803","journal-title":"J Bone Miner Res"},{"key":"2910_CR41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.10331011","volume":"7","author":"S Lundberg","year":"2012","unstructured":"Lundberg S, Qureshi AR, Olivecrona S, Gunnarsson I, Jacobson SH, Larsson TE (2012) FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy. Clin J Am Soc Nephrol 7:727\u2013734","journal-title":"Clin J Am Soc Nephrol"},{"key":"2910_CR42","first-page":"229","volume":"33","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R, Shalhoub V, Mohammadi M, Pohl EE, Lanske B et al (2014) FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J 33:229\u2013246","journal-title":"EMBO J"},{"key":"2910_CR43","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1186\/ar4060","volume":"14","author":"B Terrier","year":"2012","unstructured":"Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, Mariampillai K, Rosenzwajg M, Carpentier W, Musset L et al (2012) Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 14:R221","journal-title":"Arthritis Res Ther"},{"key":"2910_CR44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3899\/jrheum.111594","volume":"40","author":"A Abou-Raya","year":"2013","unstructured":"Abou-Raya A, Abou-Raya S, Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40:265\u2013272","journal-title":"J Rheumatol"},{"key":"2910_CR45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","volume":"20","author":"HA Austin 3rd","year":"2009","unstructured":"Austin HA 3rd, Illei GG, Braun MJ, Balow JE (2009) Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 20:901\u2013911","journal-title":"J Am Soc Nephrol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2910-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2910-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:17Z","timestamp":1558624517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2910"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2910-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}